Pretreatment of glial cell‐derived neurotrophic factor and geranylgeranylacetone ameliorates brain injury in Parkinson's disease by its anti‐apoptotic and anti‐oxidative property
Authors:
- 25 March 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 119 (7) , 5491-5502
Abstract
The aim of the present study was to determine the combined effects of glial cell‐derived neurotrophic factor (GDNF) and geranylgeranylacetone (GGA) on neuron apoptosis and oxidative stress in Parkinson's disease (PD). A mouse MPTP model of PD and cellular models of H2O2 and MPP+‐treated PC12 cells were established. Swimming, pole, and traction tests were used to detect behavioral impairment. Tyrosine hydroxylase (TH) immunohistochemistry was used to evaluate the neuron loss. TUNEL and flow cytometer method were used to identify the neuron apoptosis. MDA levels and activities of antioxidant enzymes were used to detect the oxidative damage. The PD model of mice received GDNF and GGA exhibited a significant recovery in their swim, pole, and traction scores. Moreover, the combined treatment significantly reduced the neuron apoptosis in the substantia nigra (SN) of PD mice or in H2O2 or MPP+‐induced PC12 cells compared with the single drug group. In addition, significant reduction of MDA levels and improvement of activities of CAT, SOD, and GSH‐px were observed after GDNF and GGA treatment in the PD model and H2O2 or MPP+‐induced PC12 cells. The combination of GDNF and GGA ameliorated neural apoptosis and oxidative damage in PD.Keywords
Funding Information
- National Natural Science Foundation of China (81501109, U1504813)
This publication has 46 references indexed in Scilit:
- Suppression of Alzheimer’s Disease-Related Phenotypes by Geranylgeranylacetone in MicePLOS ONE, 2013
- Toxicity of lead: a review with recent updatesInterdisciplinary Toxicology, 2012
- Preventive effects of geranylgeranylacetone on rat ethanol-induced gastritisWorld Journal of Gastroenterology, 2012
- Protective effects of octacosanol on 6-hydroxydopamine-induced Parkinsonism in rats via regulation of ProNGF and NGF signalingActa Pharmacologica Sinica, 2010
- Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal modelBMC Pulmonary Medicine, 2009
- Memantine lowers amyloid‐β peptide levels in neuronal cultures and in APP/PS1 transgenic miceJournal of Neuroscience Research, 2009
- GDNF reduces apoptosis in dopaminergic neurons in vitroNeuroReport, 1995
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983